Saltar al contenido
Merck

Sulfapyridine-like benzenesulfonamide derivatives as inhibitors of carbonic anhydrase isoenzymes I, II and VI.

Journal of enzyme inhibition and medicinal chemistry (2011-12-23)
Cemalettin Alp, Şeyda Özsoy, Nurdan Alcan Alp, Deryanur Erdem, Mehmet Serdar Gültekin, Ömer İrfan Küfrevioğlu, Murat Şentürk, Claudiu T Supuran
RESUMEN

The inhibition of two human cytosolic carbonic anhydrase (hCA, EC 4.2.1.1) isozymes I, II and human serum isozyme VI, with a series of tosylited aromatic amine derivatives was investigated. The K(I) ranges of compounds 1-14 and acetazolamide against hCA I ranged between 1.130 and- 448.2 μM, against hCA II between 0.103 and- 14.3 μM, and against hCA VI ranged between 0.340 and- 42.39 μM. Tosylited aromatic amine derivatives are thus interesting hCA I, II and VI inhibitors, and might be used as leads for generating enzyme inhibitors eventually targeting other isoforms which have not been assayed yet for their interactions with such agents.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Supelco
Sulfapyridine, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Sulfapyridine, ≥99.0%
Supelco
Sulfapyridine, VETRANAL®, analytical standard